2025. [Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost of Care Model]. Farmeconomia. Health Economics and Therapeutic Pathways. 26, 1 (Aug. 2025). DOI:https://doi.org/10.7175/fe.v26i1.1581.